6th Exosome-Based Therapeutic Development Summit
Evvnt Promotion / evvnt
Archivio
17.09.2024 - 19.09.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
Temi della conferenza
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Informazioni ed Iscrizioni:
https://go.evvnt.com/2433871-2?pid=4832
Ms. Erin Thomas
Sanità Pubblica (Public Health), Servizi sanitari
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
